Allarity Therapeutics ALLR Cash Flow Statement (2020-2026)

NASDAQ ALLR
$1.43 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.40M-1.35M-16.82M-3.08M-5.10M-5.04M-2.84M-3.35M-2.38M-4.45M0.84M-3.84M-1.63M-11.59M8.92M-2.73M-2.32M-2.81M-3.37M-2.75M
Depreciation and Depletion (Quarter)
-0.00M0.02M-0.08M0.02M0.02M0.01M
Share-based Compensation (Quarter)
0.43M0.58M5.16M1.06M-0.06M0.41M0.34M-0.12M0.18M0.18M-0.25M0.09M0.02M0.02M0.06M0.14M0.16M0.13M0.20M1.50M
Deferred Taxes (Quarter)
-0.06M0.17M-0.13M-1.23M0.00M-0.12M-0.27M0.10M-0.01M-0.43M
Gains from Investment Securities (Quarter)
0.27M0.59M
Asset Writedowns and Impairment (Quarter)
14.01M3.56M0.08M0.12M-0.20M1.11M0.10M0.02M9.59M-0.00M
Cash from Operations (Quarter)
-4.27M-3.73M-4.32M-5.75M-4.21M-4.41M-2.45M-3.20M-2.50M-5.38M-1.67M-1.40M-7.30M-5.44M-3.21M-2.69M-5.51M-3.40M-3.22M-4.50M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.95M
Depreciation & Amortization (CF) (Quarter)
-0.00M0.04M0.02M0.02M0.02M0.01M0.00M0.01M0.01M0.01M0.01M0.00M0.00M0.01M0.00M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
0.11M-1.60M0.07M5.04M0.14M-0.69M1.72M0.20M1.64M-1.74M2.07M2.84M-3.41M-3.05M-0.48M0.18M0.26M-0.00M-1.57M-0.05M
Change in Accured Expenses (Quarter)
-0.03M-0.04M7.29M-0.02M-0.03M-0.03M-0.02M-0.01M0.29M-0.29M0.05M0.24M-0.08M-0.28M3.66M-0.00M-2.32M-0.32M-0.05M-0.48M
Change in Taxes (Quarter)
-0.59M0.60M-0.01M-0.03M0.06M-0.04M-0.01M-0.01M0.03M-0.02M0.01M0.00M0.01M0.00M0.01M
Other Working Capital Changes (Quarter)
0.02M0.10M0.09M0.03M0.03M
Investing Activities
Capital Expenditures (Quarter)
0.06M
Sales of Property, Plant and Equipment (Quarter)
0.01M0.81M
Cash from Investing Activities (Quarter)
0.01M0.81M-0.02M-0.06M
Financing Activities
Other financing activities (Quarter)
3.00M-14.65M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
-0.01M1.80M2.65M-2.65M1.34M
Long-Term Debt Repayments (Quarter)
-0.01M
Short-Term Debt issuances (Quarter)
-0.06M-0.06M20.00M
Change in Capital Stock
Shares Issued (Quarter)
0.22M0.09M1.17M1.17M0.68M0.34M10.000.01M412.00313.009.0013.0011.006.000.05M0.05M0.10M
Net Equity Issued and Repurchased (Quarter)
2.77M17.25M7.50M0.04M27.65M5.40M4.24M11.14M
Misc.
Cash from Financing Activities (Quarter)
10.71M2.35M18.44M1.00M1.16M2.87M6.45M0.52M1.38M26.31M4.87M4.24M11.14M-2.56M2.31M-0.24M19.74M
Exchange Rate Effect (Quarter)
0.05M-0.63M-0.15M-0.07M-0.35M0.68M-0.45M0.31M-0.24M-0.10M-0.08M0.17M-0.08M-0.20M0.34M-0.29M-1.86M0.19M1.28M-0.06M
Change in Cash (Quarter)
6.44M-0.39M14.12M-4.95M-6.52M-4.41M-1.46M-2.04M0.37M1.07M-1.15M-0.02M19.00M-0.57M0.73M8.46M-8.05M-1.10M-3.49M15.18M
Free Cash Flow (Quarter)
-4.27M-3.73M-4.32M-5.75M-4.21M-4.41M-2.45M-3.20M-2.50M-5.38M-1.67M-1.40M-7.30M-5.44M-3.21M-2.69M-5.51M-3.40M-3.22M-4.56M
Net Cash Flow (Quarter)
6.44M-1.39M14.12M-4.95M-4.21M-4.41M-1.46M-2.04M0.37M1.07M-1.15M-0.02M19.00M-0.57M1.03M8.46M-8.08M-1.09M-3.46M15.18M